LMT
47
7
TDC
59
10
JBHT
50
-6
MS
64
7
DNB
50
-4
ESS
60
-8
KLAC
61
-2
CCL
68
-4
LH
48
-2
PLD
51
-5
DIS
60
2
SCHW
52
3
AIV
71
9
OMC
64
-2
PNW
66
3
PCG
80
3
THC
61
-3
TGT
50
-2
IP
39
-6
LB
38
-7
LMT
47
7
TDC
59
10
JBHT
50
-6
MS
64
7
DNB
50
-4
ESS
60
-8
KLAC
61
-2
CCL
68
-4
LH
48
-2
PLD
51
-5
DIS
60
2
SCHW
52
3
AIV
71
9
OMC
64
-2
PNW
66
3
PCG
80
3
THC
61
-3
TGT
50
-2
IP
39
-6
LB
38
-7
Financhill
Back

SolarEdge Technologies Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
27

SEDG
SolarEdge Technologies

Last Price:
20.36
Seasonality Move:
6.39%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
27
SolarEdge Technologies (SEDG) is a Sell

Is SolarEdge Technologies a Buy, Sell or Hold?

  • The current SolarEdge Technologies [SEDG] share price is $20.37. The Score for SEDG is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • SEDG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SEDG Stock Price Chart

What is SolarEdge Technologies's stock price today?

  • The SolarEdge Technologies share price today is $20.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SEDG is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

SEDG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.24 Sell
Relative Strength Index (14 RSI): 42.97 Sell
Chaikin Money Flow: -1032356 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.67 - 26.05) Sell
Bollinger Bands (100): (21.09 - 46.45) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

SEDG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.62 Sell
20-day SMA: 22.01 Sell
50-day SMA: 24.28 Sell
200-day SMA: 53.62 Sell
8-day EMA: 20.89 Sell
20-day EMA: 21.73 Sell
50-day EMA: 25.44 Sell
200-day EMA: 60.91 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

SolarEdge Technologies Earnings Growth & SEDG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.32 per share, an increase next quarter of $1.75 per share, a decrease this year of $10.01 per share, and an increase next year of $6.28 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

SolarEdge Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):